期刊文献+

口服甘露醇与庆大霉素治疗幽门螺杆菌感染86例临床观察 被引量:2

下载PDF
导出
摘要 目的:探讨治疗消化性溃疡的有效方法。方法:2008年4月~2011年3月来我院就诊的消化性溃疡86例。20%甘露醇注射液20~25ml于饭前1h服用,半小时后口服庆大霉素8万U,3次/d,连续应用1个月。结果:治愈(HP转阴)73例,占84.88%;总有效率94.19%。结论:口服甘露醇与庆大霉素治疗幽门螺杆菌感染,经济适用,适合在基层医院实施。
作者 谢仁红
出处 《中国民康医学》 2012年第2期174-174,206,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献10

二级参考文献10

  • 1Parente F,Maconi G,Sangaletti O,et al.Behaviour of acid secretion,gastrin release,serum pepsinogen I,and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients:a controlled study[J].Gut,1995,37:210-2
  • 2Sepuulveda A,Peterson LE,Shelton J,et al.Histological patterns of gastritis in H.pylori-infected individuals with a family history of gastric cancer[J].Am J Gastroenterol,2002,97:1365-1370.
  • 3Ching CK,Lam SK.Helicobacter pylori epidemiology in realation to peptic ulcer and gastric cancer in South and North China[J].J Gastroenterol Hepatol,1994,9:4-7.
  • 4Go MF,Graham DY.How does helicobacter pylori causes duoidenal ulcer disease:the bug,the host,or both[J].J Gastroenterol hepatol,1994,9(Suppl):8-12.
  • 5EL-Omar,Penman ID,Ardill JES,et al.Chittajallu RS,Howie C,McColl KEL.Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease[J].Gastroenterol,1995,109:681-691.
  • 6Ohkusa T,Fujiki K,Takashimizu I,et al.Improvement in atrophic gastritis and intetinal metaplasia in patients in whom Helicobacter pylori was eradicated[J].Ann Intern Med 2001,134:380-386.
  • 7赵本钰,林菁,张伟,程国利.消化性溃疡抗感染治疗[J].中国新药与临床杂志,1998,17(1):49-50. 被引量:33
  • 8严彬,雷保虎,王蕊,王燕炯,索南草.雷尼替丁与甲硝唑及庆大霉素联合治疗幽门螺杆菌感染的临床疗效观察[J].中国医院药学杂志,1999,19(4):218-219. 被引量:3
  • 9姚永莉,张万岱.幽门螺杆菌致病因子研究进展[J].世界华人消化杂志,2002,10(4):455-458. 被引量:40
  • 10王永福,孙春梅,耿立霞,许贤智,杨国安,陈鹏.幽门螺杆菌感染与胃黏膜病理改变的关系[J].中国临床医学,2004,11(1):48-50. 被引量:11

共引文献326

同被引文献24

  • 1牟方宏,魏红,胡伏莲.含庆大霉素缓释片的三联疗法根除Hp的临床研究[J].中国新药杂志,2004,13(11):1036-1039. 被引量:2
  • 2高文,胡伏莲.幽门螺杆菌感染与胃肠道外疾病[J].中国医刊,2007,42(2):22-24. 被引量:30
  • 3Conen Henry.World Gastroenterology Organization global guideline:Helicobacter pylori in developing countries[J].Journal of Digestive disease,2011(5):319-326.
  • 4中华医学会消化病分会幽门螺杆菌学组/全国幽门螺杆菌科研协作组.中国幽门螺杆菌耐药状况以及耐药对治疗的影响-全国多中心临床研究[J].胃肠病学,2007(12):525-530.
  • 5The Maastricht IV/Florence Consensus.Management of Helicobacter pylori infection[J].Gut,2012(61):646-664.
  • 6中华医学会消化病学分会.第四次全国幽门螺杆菌感染处理共识[J].中华胃肠病学,2012(10):618-625.
  • 7Ghadir MR,Shafaghi A.Furazolidone,amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease[J].The Turkish Journal of Gastroenterology,2011(1):1-5.
  • 8Berning M,Krasz S.Should quinolones come first in Helicobacter pylori therapy[J].Therapeutic Advances in Gastroenterology,2011(2):103-114.
  • 9O'Connor A,Taneike I,Nami A,et al.Helicobacter pylori resistance rates for levofloxacin、tetracycline and rifabutin among Irish isolates at a reference center[J].Irish Journal of Medical Science,2013(4):693-695.
  • 10Di Caro S,Objetti V,Zocco MA,et al.Mono,dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication[J].Alimentary Pharmacology&Therapeutics,2002(3):527-532.

引证文献2

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部